Crédit Industriel et Commercial’s Cidara Therapeutics CDTX Stock Holding History

Crédit Industriel et Commercial’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22,500	Closed	-$4.97M	–	365
2025 Q4	$4.97M	Buy	+22,500	New	+$3.64M	0.38%	66

Crédit Industriel et Commercial's CDTX Position: Q1 2026 in Review

Crédit Industriel et Commercial sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 22,500 shares — an estimated $4.97M sold.

Crédit Industriel et Commercial first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $4.97M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Crédit Industriel et Commercial reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Crédit Industriel et Commercial sold 22,500 Cidara Therapeutics shares in Q1 2026, an estimated $4.97M.
Crédit Industriel et Commercial first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Crédit Industriel et Commercial's Cidara Therapeutics position peaked at $4.97M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Crédit Industriel et Commercial's 13F filing for Q1 2026, filed 29 Apr 2026.